Knut Wendelin

Prof. Ernst Nathan Str. 1
Nuernberg, BY 90419, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

Journal: Leukemia & lymphoma
Published: August 02, 2026

Early allogeneic stem cell transplantation after melphalan-induced aplasia leads to long-term survival in patients with primary refractory AML.

Early allogeneic stem cell transplantation after melphalan-induced aplasia leads to long-term survival in patients with primary refractory AML.

Journal: Annals of hematology
Published: May 12, 2025

Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.

Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.

Journal: Leukemia & lymphoma
Published: February 08, 2025

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis.

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis.

Journal: Bone marrow transplantation
Published: August 04, 2024

Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.

Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.

Journal: British journal of haematology
Published: February 09, 2024

Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

Journal: Transplantation and cellular therapy
Published: June 14, 2022

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment.

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment.

Journal: Leukemia
Published: December 20, 2021

General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia.

General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia.

Journal: Haematologica
Published: September 10, 2020

Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma.

Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma.

Journal: Annals of hematology
Published: October 07, 2018

Spontaneous remission of acute lymphoblastic leukemia: A case report.

Spontaneous remission of acute lymphoblastic leukemia: A case report.

Journal: Oncology letters
Published: May 03, 2017

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.

Journal: Lancet (London, England)
Published: August 11, 2012

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.

Journal: Blood
Published: April 12, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026